WILLIAM W. STEAD, M.D.; ASIM K. DUTT, M.D.
This content is PDF only. Please click on the PDF icon to access.
A quiet revolution has been occurring in the treatment of tuberculosis through use of a combination of drugs that can kill tubercle bacilli. Field trials based on sound theoretical considerations and experimental corroboration (1-3) have been conducted over the past 10 years; these trials have demonstrated a remarkable efficacy of greatly shortened periods of treatment (4, 5). It has even been found that much of the medication can be given as "pulse therapy" twice weekly rather than daily, as has been the usual practice (6, 7). This new short-course therapy has recently been given limited sanction by the Center for
STEAD WW, DUTT AK. An Advance in Treatment of Tuberculosis. Ann Intern Med. ;93:364–365. doi: 10.7326/0003-4819-93-2-364
Download citation file:
Published: Ann Intern Med. 1980;93(2):364-365.
Infectious Disease, Mycobacterial Infections.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use